Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 854

The DOI matches its Crossref record; 826 of the 826 references it cites were found in a registry or an index.

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Open access
Bandelow, Borwin, Zohar, Joseph, Hollander, Eric, Kasper, Siegfried, Möller, Hans-Jürgen, WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, Borwin, Zohar, Joseph, Hollander, Eric, Kasper, Siegfried, Möller, Hans-Jürgen, WFSBP TASK FORCE ON TREATMENT GUIDE · 2008 · The World Journal of Biological Psychiatry

Abstract

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15622970802465807

Cites

826 of 826 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 601–800 of 826

Research works printed but not linked: 116

  1. Altshuler LL, 2001, Postgrad Med, 1
  2. Amore M, 1999, Hum Psychopharmacol Clin Exp, 14, 435, 10.1002/(SICI)1099-1077(199908)14:6<435::AID-HUP109>3.0.CO;2-B · doi:10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b
  3. Bakish D, 1996, Psychopharmacol Bull, 32, 135
  4. Ballenger JC, 2001, J Clin Psychiatry, 62, 53
  5. Bandelow B, 2004, Br J Psychiatry, 184, 271, 10.1192/bjp.184.3.271 · DOI
  6. Bandelow B, 2002, Eur Neuropsychopharmacol, 12, S364, 10.1016/S0924-977X(02)80585-5 · doi:10.1016/s0924-977x(02)80585-5
  7. Bradwejn J, 1993, Can J Psychiatry, 38, S109
  8. Braun P, 1990, J Clin Psychiatry, 51, 236
  9. Bystritsky A, 2008, Psychopharmacol Bull, 41, 46
  10. 10.3109/10401239909147053 · doi:10.3109/10401239909147053
  11. Chao IL, 2004, Pharmacopsychiatry, 37, 239, 10.1055/s-2004-832600 · DOI
  12. Charney DS, 1989, J Clin Psychiatry, 50, 418
  13. Charney DS, 1986, J Clin Psychiatry, 47, 580
  14. Chouinard G, 1990, Psychopharmacol Bull, 26, 279
  15. 10.3109/10401230490281609 · doi:10.3109/10401230490281609
  16. Davis LL, 2008, Psychopharmacol Bull, 41, 8
  17. DeVeaugh-Geiss J, 1989, Psychopharmacol Bull, 25, 36
  18. Dieleman GC, 2008, Tijdschr Psychiatr, 50, 43
  19. Dunner DL, 1986, J Clin Psychiatry, 47, 458
  20. Eriksson T, 2007, Int Clin Psychopharmacol, 22, 57
  21. Feighner JP, 1987, J Clin Psychiatry (Suppl), 48, 3
  22. Feighner JP, 1982, J Clin Psychiatry, 43, 103
  23. Feltner DE, 2003, J Clin Psychopharmacol, 23, 240
  24. Ferreri M, 1994, Encéphale, 20, 785
  25. 10.1037/0022-006X.65.6.1026 · doi:10.1037/0022-006x.65.6.1026
  26. Fesler FA, 1991, J Clin Psychiatry, 52, 361
  27. Foa EB, 2000, J Clin Psychiatry, 61, 43
  28. Frommberger U, 2004, Fortschr Neurol Psychiatr, 72, 411, 10.1055/s-2004-818455 · doi:10.1055/s-2004-818455
  29. Gelpin E, 1996, J Clin Psychiatry, 57, 390
  30. Gruber RP, 1971, Dis Nerv Syst, 32, 180
  31. Hamner MB, 2001, Ann Clin Psychiatry, 13, 141, 10.3109/10401230109148960 · DOI
  32. 10.3109/10401230009147096 · DOI · Paper page
  33. Hoehn-Saric R, 1988, J Clin Psychiatry, 49, 293
  34. Hoffart A, 1993, J Clin Psychiatry, 54, 481
  35. 10.1037/0022-006X.72.3.393 · DOI
  36. Hofmann SG, 2008, J Clin Psychiatry, e1
  37. Husain MM, 1993, Am J Psychiatry, 150, 1899
  38. Jenike MA, 1991, J Clin Psychiatry, 52, 13
  39. Khanna S, 1988, Convuls Ther, 4, 314
  40. Klerman GL, 199, Social Morbidity Health Care Utilization J, 265, 742
  41. Kocabasoglu N, 2004, Eur Neuropsychopharmacol, 14, S304, 10.1016/S0924-977X(04)80382-1 · doi:10.1016/s0924-977x(04)80382-1
  42. Koran LM, 2007, Am J Psychiatry, 164, 5
  43. Lee C, 2002, J Clin Psychol Psychother, 58, 1071
  44. Lenox-Smith AJ, 2003, Br J Gen Pract, 53, 772
  45. Li D, 2001, J Psychiatry Neurosci, 26, 190
  46. Lidren DM, 1994, J Consult Clin Psychol, 62, 865, 10.1037/0022-006X.62.4.865 · DOI · Paper page
  47. Liebowitz MR, 1988, J Clin Psychiatry, 49, 252
  48. 10.1002/(SICI)1520-6394(1999)10:3%3C89::AID-DA1%3E3.0.CO;2-5 · doi:10.1002/(sici)1520-6394(1999)10:3<89::aid-da1>3.0.co;2-5
  49. Livingston MG, 1994, Br J Hosp Med, 51, 281
  50. Lopes AC, 2008, Biol Psychiaty, 63, 131s, 10.1016/j.biopsych.2007.11.007 · doi:10.1016/j.biopsych.2007.11.007
  51. López-Ibor JJ, 1975, Neurological treatment in psychiatry, pain and epilepsy, 151
  52. Lum M, 1990, Biol Psychiatry :A, 27, 164
  53. Maletzky B, 1994, Convuls Ther, 10, 34
  54. Marazziti D, 1999, Am J Psychiatry, 156, 1834, 10.1176/ajp.156.11.1834-a · doi:10.1176/ajp.156.11.1834-a
  55. Marmar CR, 1996, J Clin Psychiatry, 57, 66
  56. Mavissakalian M, 1983, Psychopharmacol Bull, 19, 116
  57. Mavissakalian M, 1986, J Clin Psychol, 47, 117
  58. Meibach RC, 1987, J Clin Psychiatry, 48, 355
  59. Misri S, 2000, Can Family Phys, 46, 626
  60. Mohlman J, 2003, Am J Geriatr Psychiatry, 11, 24
  61. Montoya A, 2002, Neurosurgery, 50, 1043
  62. Munjack DJ, 1989, J Clin Psychopharmacol, 9, 22
  63. Munjack DJ, 1990, J Clin Psychiatry, 51, 35
  64. Nelson J, 1999, Can Soc Clin Pharmacol, 6, 69
  65. Neylan TC, 2006, Am J Psychiatry, 163, 2186, 10.1176/ajp.2006.163.12.2186 · doi:10.1176/ajp.2006.163.12.2186
  66. Nicolini H, 2008, Psychol Med, 1
  67. NIMH 1976. National Institute of Mental Health. 028 CGI. Clinical Global Impressions. In: Guy E, ECDEU Assessment manual for psychopharmacology. Revised edition. Rockville, MD: NIMH. p 217–222.
  68. Noyes R, 1996, J Clin Psychiatry, 57, 349
  69. Nutt DJ, 1998, J Clin Psychiatry, 59, 4
  70. Ontiveros A, 1992, J Psychiatry Neurosci, 17, 78
  71. Pastrana Jiménez JI, 2007, Actas Esp Psiquiatr, 35, 351
  72. Pigott TA, 1992, J Clin Psychopharmacol, 12, 11
  73. Pollack MH, 2003, Psychopharmacol Bull, 37, 53
  74. Pollack MH, 1994, J Clin Psychiatry, 55, 200
  75. Pollack MH, 1996, Psychopharmacol Bull, 32, 667
  76. Pollack MH, 1997, J Clin Psychiatry, 58, 19
  77. Pols H, 1993, Acta Psychiatr Belg, 93, 169
  78. Power KG, 1990, Br J Gen Pract, 40, 289
  79. Prasko J, 2006, Neuroendocrinol Lett, 27, 473
  80. Prasko J, 2006, Neuroendocrinol Lett, 27, 327
  81. 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
  82. Ravizza L, 1996, Psychopharmacol Bull, 32, 677
  83. 10.1037/0022-006X.70.4.86 · doi:10.1037/0022-006x.70.4.86
  84. Rickels K, 1982, J Clin Psychiatry, 43, 81
  85. Riddle MA, 1996, Psychopharmacol Bull, 32, 399
  86. Rizley R, 1986, Psychopharmacol Bull, 22, 167
  87. Rothbaum B, 1997, Bull Menninger Clinic, 61, 317
  88. Rothbaum BO, 2008, J Clin Psychiatry, e1
  89. Rück C, 2006, Capsulotomy in anxiety disorders [thesis]
  90. 10.1176/appi.ajp.164.2.290 · DOI
  91. 10.1002/da.20271 · DOI
  92. Sachdev P, 1995, J Nerv Ment Dis, 183, 408, 10.1097/00005053-199506000-00010 · doi:10.1097/00005053-199506000-00010
  93. 10.1345/aph.1C040 · doi:10.1345/aph.1c040 · Paper page
  94. Saxena S, 1996, J Clin Psychiatry, 57, 303
  95. Seedat S, 2004, J Clin Psychiatry, 65, 244
  96. Shader RI, 1993, New Engl J Med, 13, 1398
  97. Sharp DM, 1997, Br J Gen Pract, 47, 150
  98. Simon NM, 2003, Psychopharmacol Bull, 37, 66
  99. Simon NM, 2008, J Clin Psychiatry, e1
  100. Stein DJ, 1999, S Afr Med J, 89, 402
  101. 10.3109/10401230600948431 · doi:10.3109/10401230600948431
  102. Stein DJ, 2007, Eur Neuropsychophar17(Suppl, 4, S509, 10.1016/S0924-977X(07)70784-8 · doi:10.1016/s0924-977x(07)70784-8
  103. Strand M, 1990, J Clin Psychiatry (Suppl), 51, 40
  104. Telch MJ, 1995, J Consult Clin Psychol, 63, 823, 10.1037/0022-006X.63.5.823 · doi:10.1037/0022-006x.63.5.823
  105. Tesar GE, 1991, J Clin Psychiatry, 52, 69
  106. Tiffon L, 1994, J Clin Psychiatry, 55, 66
  107. Todorov C, 2000, Can J Psychiatry, 45, 257, 10.1177/070674370004500304 · doi:10.1177/070674370004500304
  108. Turner SM, 1994, J Consult Clin Psychol, 62, 350, 10.1037/0022-006X.62.2.350 · DOI · Paper page
  109. van Ameringen M, 1993, J Clin Psychiatry, 54, 27
  110. van der Kolk BA, 1994, J Clin Psychiatry, 55, 517
  111. Wetherell JL, 2003, J Consult Clin Psychol, 71, 31, 10.1037/0022-006X.71.1.31 · DOI · Paper page
  112. WHO, 1991, Clinical Descriptions and Diagnostic Guidelines
  113. Woodman CL, 1994, J Clin Psychiatry, 55, 134
  114. Worthington JJ, 1998, Psychopharmacol Bull, 34, 199
  115. Zitterl W, 1999, Wien Klin Wochenschr, 111, 439
  116. Zohar J, 2006, Obsessive-compulsive disorder and comorbidity, 79

Cited by

See all 854

Metadata

Authors
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., & WFSBP TASK FORCE ON TREATMENT GUIDE
Venue
The World Journal of Biological Psychiatry
Published
2008-01
Volume
9
Issue
4
Pages
248-312
ISSN
  • 1562-2975 (ISSN-L)
  • 1814-1412
OpenAlex
W1966065460
Cited by
854
References
826
FWCI
73.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.